Ospedale Fabrizio Spaziani

The site focuses on cardiovascular disease trials aiming to improve outcomes for patients with high risk or established disease. Studies evaluate innovative peptide therapies to lower event rates in individuals with hypertension and existing heart conditions.

• Risk reduction in hypertension
• Evaluation of novel peptide therapeutics
• Assessment of cardiovascular event endpoints

At Ospedale Fabrizio Spaziani, investigators are exploring strategies to lower cardiovascular events in patients with hypertension and established heart disease.

Research at the department includes Acute Lymphoblastic Leukemia studies that test chemo‑free regimens to enhance survival. Trials in Acute Myeloid Leukemia evaluate targeted antibody‑drug conjugates to achieve deeper remission.

• Chemo‑free induction strategies
• Monoclonal antibody consolidation
• Minimal residual disease eradication

The oncology clinic is enrolling adult patients to assess innovative therapies that may reduce treatment toxicity while maintaining efficacy.

The center conducts breast cancer trials comparing sequential versus concurrent endocrine and chemotherapy to prevent recurrence. In metastatic colorectal cancer research, investigators examine optimal sequencing of targeted agents to extend overall survival.

• Sequencing of anti‑EGFR and multikinase inhibitors
• Hormone‑therapy timing in early breast cancer
• Combination strategies in colorectal cancer

These studies at the Ambulatorio di Oncologia aim to refine treatment pathways for common cancers affecting the region.